Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma

A TLR9 agonist in combination with a PD-1 inhibitor produced powerful antitumor responses in a clinical trial despite TLR9 agonists as monotherapies failing to generate systemic antitumor immune responses due to immunosuppressive effects. However, the mechanism involved in the improved response indu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Zhou, Binghai, Yan, Jiuliang, Guo, Lei, Zhang, Bo, Liu, Shuang, Yu, Mincheng, Chen, Zheng, Zhang, Kewei, Zhang, Wentao, Li, Xiaoqiang, Xu, Yongfeng, Xiao, Yongsheng, Zhou, Jian, Fan, Jia, Hung, Mien-Chie, Li, Hui, Ye, Qinghai
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7255037/
https://ncbi.nlm.nih.gov/pubmed/32483468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.44417
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados